Published in Hospital Law Weekly, May 24th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Lipid Sciences.
Report 1: Lipid Sciences, Inc. (Nasdaq:LIPD) announced today that Dr. Philip Barter and Dr. John Kastelein, two pre-eminent researchers and clinical trial experts in the field of lipids and lipoproteins, have joined the Company's Scientific Advisory Board. They now become part of a team headed by Dr. H. Bryan Brewer, an internationally-recognized lipid metabolism expert. Dr. Brewer is the architect of Lipid Sciences' HDL Therapy platform (HDL Selective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.